Wordt geladen...
Single dose oral ranolazine pharmacokinetics in patients receiving maintenance hemodialysis
Purpose: Ranolazine is a novel anti-angina treatment approved in the United States for chronic stable angina. Ranolazine pharmacokinetics have not been studied previously in patients who receive maintenance hemodialysis. This study describes the pharmacokinetics of ranolazine and three major metabol...
Bewaard in:
| Gepubliceerd in: | Ren Fail |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Taylor & Francis
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6442103/ https://ncbi.nlm.nih.gov/pubmed/30909832 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/0886022X.2019.1585371 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|